Can-Fite BioPharma Ltd. (CANF) Insider Trading Disclosures
Can-Fite BioPharma Ltd. (CANF) is a publicly traded company on the NYSE, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: CANF
CIK: 1536196
Exchange: NYSE
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: L3
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Kost Forer Gabbay & Kasierer
Auditor SinceSince 12/31/2016 12:00:00 AM
Lead Engagement PartnerGil Senderovich
Audit LocationTel Aviv, Israel
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| EFFECT | 2026-10-09 | — | EFFECT Filing | 9999999995-26-003201 | View SEC Doc Filr Page |
| EFFECT | 2026-10-09 | — | EFFECT Filing | 9999999995-26-003206 | View SEC Doc Filr Page |
| 424B3 | 2026-10-09 | — | PROSPECTUS | 0001213900-26-108576 | View SEC Doc Filr Page |
| F-3 | 2026-09-25 | — | REGISTRATION STATEMENT | 0001213900-26-103584 | View SEC Doc Filr Page |
| F-3/A | 2026-09-25 | — | AMENDMENT NO. 1 TO FORM F-3 | 0001213900-26-103531 | View SEC Doc Filr Page |
| EFFECT | 2026-09-11 | — | EFFECT Filing | 9999999995-26-002945 | View SEC Doc Filr Page |
| EFFECT | 2026-09-11 | — | EFFECT Filing | 9999999995-26-002944 | View SEC Doc Filr Page |
| D | 2026-09-10 | — | D Filing | 0001213900-26-098844 | View SEC Doc Filr Page |
| 6-K | 2026-09-09 | 2026-09-09 | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-26-098205 | View SEC Doc Filr Page |
| POS AM | 2026-09-08 | — | POST-EFFECTIVE AMENDMENT NO. 11 TO FORM F-1 | 0001213900-26-098061 | View SEC Doc Filr Page |
| POS AM | 2026-09-08 | — | POST-EFFECTIVE AMENDMENT NO. 11 TO FORM F-1 | 0001213900-26-098060 | View SEC Doc Filr Page |
| 6-K | 2026-09-08 | 2026-06-30 | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-26-097856 | View SEC Doc Filr Page |
| 6-K | 2026-09-03 | 2026-09-03 | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-26-097048 | View SEC Doc Filr Page |
| 6-K | 2026-09-02 | 2026-09-02 | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-26-096480 | View SEC Doc Filr Page |
| 6-K | 2026-09-02 | 2026-09-02 | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-26-096442 | View SEC Doc Filr Page |
| F-3 | 2026-08-28 | — | REGISTRATION STATEMENT | 0001213900-26-095053 | View SEC Doc Filr Page |
| 6-K | 2026-08-17 | 2026-08-17 | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-26-090478 | View SEC Doc Filr Page |
| 6-K | 2026-08-12 | 2026-08-12 | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-26-088029 | View SEC Doc Filr Page |
| 6-K | 2026-08-03 | 2026-08-03 | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-26-084244 | View SEC Doc Filr Page |
| 6-K | 2026-07-20 | 2026-07-20 | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-26-079394 | View SEC Doc Filr Page |
| 6-K | 2026-07-14 | 2026-07-14 | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-26-077775 | View SEC Doc Filr Page |
| 6-K | 2026-07-06 | 2026-07-06 | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-26-075199 | View SEC Doc Filr Page |
| 6-K | 2026-07-01 | 2026-07-01 | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-26-073978 | View SEC Doc Filr Page |
| 6-K | 2026-06-26 | 2026-06-26 | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-26-072299 | View SEC Doc Filr Page |
| 6-K | 2026-06-22 | 2026-06-22 | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-26-070365 | View SEC Doc Filr Page |